Trial Profile
Steroid-sparing management of the salmeterol/fluticasone 50/100 microg b.i.d. [twice daily] combination compared to fluticasone 200 microg b.i.d. in children and adolescents with moderate asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms VIAPAED
- Sponsors GlaxoSmithKline; GSK
- 04 Oct 2008 This study was presented during the proceedings of the 18th Annual Congress of the European Respiratory Society.
- 03 Nov 2006 New trial record.